학술논문
Evenamide, as an add-on to antipsychotics, benefits patients with treatment resistant schizophrenia: 6-month interim results from the first 100 patients in an ongoing international randomized study
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
17783585